 |
|
|
| |
48 Weeks TDF Treatment Results in Potent Viral Suppression and A Favorable Safety Profile in Chinese Chronic Hepatitis B Patients
|
| |
| |
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL), June 2013, Singapore
JL Hou1*, ZL Gao2, Q Xie3, JM Zhang4, JF Sheng5, J Cheng6, CW Chen7, Q Mao8, W Zhao9, H Ren10 , DM Tan11, JQ Niu12, SJ Chen13, C Pan14, H Tang15, H Wang16, YM Mao17,JD Jia18, Q Ning19, M Xu20, SM Wu20, J Li22, XX Zhang3; Y Ji23; J Dong24, J Li24
* Corresponding Author: Jin Lin Hou M.D. Director & Professor, Hepatology Unit and Department of Infectious Disease, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
1Nanfang Hospital, Guangzhou, China; 23rd Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; 3Ruijin Hospital Affiliated to Jiaotong University, Shanghai, China; 4Huashan Hospital Affiliated to Fudan University, Shanghai, China;51st Affiliated Hospital of ZheJiang University, Hangzhou, China; 6Beijing Ditan Hospital, Beijing, China; 7Shanghai the 85th Hospital Affiliated to Nanjing Military, Shanghai, China; 8Southwest Hospital, Third Military Medical University, Chongqing, China; 92nd Hospital of Nanjing, Nanjing, China; 102nd Affiliated Hospital Chongqing Medical University, Chongqing, China;11Xiangya Hospital Central-South University, Changsha, China; 121st Affi liated Hospital of Jilin University, Changchun, China; 13Jinan Hospital for Infectious Disease, Jinan, China; 14 Fuzhou Infectious Disease Hospital, Fuzhou, China; 15West China Hospital, Sichuan University, Chengdu, China; 16Peking University People's Hospital, Beijing, China; 17Renji Hospital Affiliated to Shanghai JiaoTong University, Shanghai, China; 18Beijing Friendship Hospital Affi liated to Capital University, Beijing, China; 19Tongji Hospital of Tongji Medical College, Wuhan, China; 20Guangzhou Eighth Municipal People's Hospital, Guangzhou, China; 21Shanghai Public Health Clinical Center, Shanghai, China; 22The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; 23Zhongshan Hospital, Fudan University, Shanghai, China ; 24GlaxoSmithKline R&D China.
|
| |
|
|
|
|
|
